Nivagen Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Nivagen Pharmaceuticals is a company that focuses on developing, acquiring, and selling generic prescription drugs and over-the-counter products in North America. The company aims to offer high-quality products at affordable prices by utilizing partnerships with FDA-approved manufacturing facilities worldwide. The generic prescription market in the US is currently valued at around $60 billion, and there will be more than $120 billion worth of products losing patent protection in the next decade. Nivagen believes that its strategic partnership approach, collaborating with efficient pharmaceutical companies globally, will result in cost savings for consumers and added value for everyone involved in the supply chain.
Nivagen Pharmaceuticals has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Aug 2023.
That round is below the $5.7M median round size for Data and Analytics companies tracked on FundedIQ over the last two years.
Nivagen Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Nivagen Pharmaceuticals Funding Rounds
Nivagen Pharmaceuticals Founders and Leadership Team
Contact details for the Nivagen Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Nivagen Pharmaceuticals Funding Compared to Other Data and Analytics Startups
Nivagen Pharmaceuticals' latest round of $5.0M is below the median round in Data and Analytics. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nivagen Pharmaceuticals in Data and Analytics and Sacramento
Companies Similar to Nivagen Pharmaceuticals
Tamr is a company that specializes in making enterprise data more unified and easily accessible. The team at…
Fragment develops a ledger database application programming interface platform to build finance applications.…
Silk is a top platform that efficiently transfers essential data to the cloud and maintains performance…
By taking a big data approach, Fin helps companies improve business process definition, design better, more…
IDMission offers cutting-edge technology for Identity Verification. Through IDMission, businesses can create…
TRM Labs is a blockchain intelligence startup that aids financial institutions, cryptocurrency companies, and…
Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a…
Euno is a platform for governing data models that offers a new and innovative way to handle dynamic data. It…
CivilGrid is a platform that uses various types of data related to utilities, environment, and geotechnics to…
Wavelogix creates a platform for monitoring and testing infrastructure using IoT sensors and data analytics.…
Centralize is a tech company that uses tools and input from stakeholders to assess interactions at different…
Abstract Security has created a revolutionary platform, equipped with an AI-powered assistant, to better…
Nivagen Pharmaceuticals Funding FAQs
What does Nivagen Pharmaceuticals do?
Nivagen Pharmaceuticals is a company that focuses on developing, acquiring, and selling generic prescription drugs and over-the-counter products in North America. The company aims to offer high-quality products at affordable prices by utilizing partnerships with FDA-approved manufacturing facilities worldwide. The generic prescription market in the US is currently valued at around $60 billion, and there will be more than $120 billion worth of products losing patent protection in the next decade. Nivagen believes that its strategic partnership approach, collaborating with efficient pharmaceutical companies globally, will result in cost savings for consumers and added value for everyone involved in the supply chain.
How much funding has Nivagen Pharmaceuticals raised?
Nivagen Pharmaceuticals has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Aug 2023.
When did Nivagen Pharmaceuticals last raise funding?
Nivagen Pharmaceuticals' most recent funding round on record is an undisclosed round of $5.0M, announced in Aug 2023.
Who is the CEO of Nivagen Pharmaceuticals?
Jay Shukla is listed as CEO at Nivagen Pharmaceuticals.
Where is Nivagen Pharmaceuticals headquartered?
Nivagen Pharmaceuticals is based in Sacramento, California, United States.
How many employees does Nivagen Pharmaceuticals have?
Nivagen Pharmaceuticals is in the 51-100 employee band.
How does Nivagen Pharmaceuticals' funding compare to other Data and Analytics startups?
Nivagen Pharmaceuticals' latest round of $5.0M is below the $5.7M median round size for Data and Analytics companies on FundedIQ across 1,842 tracked companies over the last two years.
About FundedIQ's Nivagen Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nivagen Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.